Renew Medical Center provides a groundbreaking treatment that can alleviate the symptoms of Diabetic Kidney Disease and bring relief to those who suffer from it.

Renew Medical Center is at the forefront of treating diabetic kidney disease with their innovative MicroDose treatment. Unlike traditional drug-based therapies, MicroDose administers insulin as a hormone, directly targeting the underlying cause of diabetes - metabolic failure. By replicating natural physiological processes, MicroDose effectively reduces insulin resistance, which facilitates the absorption of blood sugar into cells, where it's converted into energy. This groundbreaking approach has shown promising results in improving the management of diabetic kidney disease.


By using the MicroDose treatment, the body can produce more cellular energy, which may aid in the growth, repair, and regeneration of impaired tissues and organs. This approach not only helps stabilize complications related to diabetes and other metabolic disorders but, in numerous instances, has also been proven to reverse them.

The Revolutionary Approach of "Physiological Insulin Sensitivity Restoration" with MDS. How is this different from other treatments?


The MicroDose system (MDS) treatment approach uses the "pulse-rest" intervals of insulin production to reactivate alternative insulin-signaling pathways, which can improve kidney function and potentially reverse kidney tissue damage.

This treatment option, developed in the USA  specifically designed to restore the natural insulin cycle seen in healthy individuals, which can help improve kidney function, prevent proteinuria loss, and reduce further damage.

The primary factors contributing to kidney disease are Diabetes and Hypertension. The MicroDose system serves as an optimal solution for managing both conditions.

With MDS treatment  insulin sensitivity is improved, the following benefits may be observed for individuals with kidney disease:

  1. Improved blood glucose control: Restoring insulin sensitivity can help maintain proper blood glucose levels, preventing further damage to the kidneys caused by high blood sugar.
  2. Reduced protein loss: PISR with MDS may help reduce protein loss, which is a common issue in kidney disease. When the kidneys are not functioning properly, they may leak protein into the urine, leading to proteinuria. By improving insulin sensitivity, this therapy may help minimize protein loss and alleviate the progression of kidney disease.
  3. Lower blood pressure: Insulin resistance is often associated with high blood pressure, which can strain the kidneys and contribute to kidney damage. By addressing insulin resistance, PISR with MDS may help lower blood pressure, reducing the risk of kidney-related complications.


MDS helps in lowering blood pressure levels, reducing the strain on the blood vessels in the kidneys and reducing the risk of kidney damage and proteinuria. By improving insulin sensitivity and addressing insulin resistance, this therapy may also have additional benefits in managing metabolic disorders that can contribute to kidney disease, such as obesity and type 2 diabetes.

Typical Care Plan for Patients with Kidney Disease.
At our facility, we understand that each patient's degree of insulin resistance and efficiency of carbohydrate metabolism is unique. That's why we start with a consultation to determine medical necessity and establish a physician-directed, individualized care plan.
The care plan we develop for each patient typically includes an "Induction Phase" of two infusions per week, reducing to one per week for around 90 days. This is followed by a "Maintenance Phase" focused on finding the optimal balance between metabolism and insulin sensitivity, with a goal of extending the time between treatments for as long as possible.
Patients with conditions such as Kidney disease, High blood pressure, Type 2 Diabetes, Prediabetes, and Nondiabetic conditions usually begin their treatment with three-hour infusions during the Induction Phase. As the treatment progresses, the infusions are typically reduced to two hours, allowing them to maintain optimized metabolism and insulin sensitivity for four to six weeks between treatments.


Patients seeking MDS treatment can contact us to schedule an appointment with our physicians.



Highly personalized care. Cutting-edge technologies. Highly Skilled and Experienced team. Clinical excellence. Quality standards

Patient testimonials.


Bhasker Reddy

Tr Reddy

Bala Naidu

Padma Tulasi

Sravan Kumar


What doctors have to say about MDS

Dr Naveed

Dr Saabir

Azharuddin Nagur

Patients seeking MDS treatment can contact us to schedule an appointment with our physicians.

Enquire now


MDS, which has been approved by the FDA, is a treatment method used for Insulin Resistance, which is the leading factor in the development of various Metabolic Disorders.MDS, which has been approved by the FDA, is a treatment method used for Insulin Resistance, which is the leading factor in the development of various Metabolic Disorders.
The restorative and regenerative properties of MDS have been shown to be advantageous for patients with CKD, as it can enhance kidney function and lower the likelihood of complications. This is especially important for individuals with advanced CKD, as it can aid in slowing down the progression of the disease by repairing, restoring, and regenerating tissues.
In addition to its other benefits, MDS has demonstrated effectiveness in managing blood pressure. High blood pressure is a prevalent complication in CKD, and it can exacerbate the condition. MDS has the ability to regulate blood pressure, lowering the likelihood of complications related to CKD.
MDS has been proven to be effective in stopping the loss of proteinuria and decreasing creatinine levels in the blood. Proteinuria is the presence of excess protein in the urine, which can be a sign of kidney damage. High creatinine levels in the blood can also indicate impaired kidney function. By reducing proteinuria and creatinine levels, MDS is able to improve kidney function and halt the progression of CKD.
To address the unique degree of insulin resistance and carbohydrate metabolism efficiency in each patient, a consultation is necessary to establish an individualized care plan under the direction of a physician. This plan typically includes an "Induction Phase" consisting of 2 infusions per week, followed by a reduction to 1 infusion per week for approximately 90 days. The "Maintenance Phase" focuses on achieving the ideal balance between insulin sensitivity and metabolism, while extending the time between treatments. Patients with type 2 diabetes, prediabetes, and non-diabetic conditions may be able to reduce their infusion time from 3 hours to 2 hours and maintain an optimized metabolism and insulin sensitivity for four to six weeks between infusions.
Patients can experience a range of benefits from this treatment, including increased energy levels, improved quality of sleep, enhanced kidney function, and reduced dosage of current medications. Additionally, they may experience a reduction in depression, an overall sense of well-being, a significant decrease in insulin requirements, and a reduction of excess medication to mitigate comorbid complications.
It's important to note that MDS is not a permanent cure, and if patients discontinue therapy, any improvements gained from the treatment will gradually fade or diminish over time.
The MDS treatment is presently accessible at Renew medical centers located in Bengaluru, Mumbai, and Hyderabad.

Kidney Renew in the News

Other services at renew medical center

+91-800 874 5871